scholarly article | Q13442814 |
P356 | DOI | 10.1016/S1074-7613(04)00107-4 |
P698 | PubMed publication ID | 15142530 |
P50 | author | Horst Mossmann | Q80227790 |
Christoph Hölscher | Q91743109 | ||
Irmgard Förster | Q37837842 | ||
Magdalena Radwanska | Q57082742 | ||
P2093 | author name string | De'Broski R Herbert | |
Anita Schwegmann | |||
Frank Brombacher | |||
Markus Mohrs | |||
Richard Kirsch | |||
Björn Claussen | |||
Berenice Arendse | |||
Pauline Hall | |||
Mosiuoa Leeto | |||
P2860 | cites work | IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis | Q73869153 |
SOCS-1 participates in negative regulation of LPS responses | Q78518680 | ||
IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype | Q24798167 | ||
Alternative activation of macrophages | Q27860939 | ||
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes | Q29547633 | ||
An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow | Q29615498 | ||
Other functions, other genes: alternative activation of antigen-presenting cells | Q33540045 | ||
Immunology of hepatosplenic schistosomiasis mansoni: a human perspective | Q33798189 | ||
An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response | Q33853821 | ||
Interleukin-4 receptor alpha-deficient BALB/c mice show an unimpaired T helper 2 polarization in response to Leishmania major infection | Q34003756 | ||
Central role for interleukin-4 in regulating nitric oxide-mediated inhibition of T-cell proliferation and gamma interferon production in schistosomiasis | Q34115626 | ||
Somatostatin and intestinal schistosomiasis: therapeutic and neuropathological implications in host-parasite interactions | Q34459692 | ||
The immunobiology of schistosomiasis | Q34718128 | ||
Novel IL-12 family members shed light on the orchestration of Th1 responses | Q35107889 | ||
SOCS3 negatively regulates IL-6 signaling in vivo | Q38354512 | ||
An improved chromogenic substrate endotoxin assay for clinical use | Q39517802 | ||
Cutting edge: IL-4 receptor expression by non-bone marrow-derived cells is required to expel gastrointestinal nematode parasites. | Q39586138 | ||
IL-10 is critical for host resistance and survival during gastrointestinal helminth infection. | Q39594770 | ||
Two different IL-13 receptor chains are expressed in normal human skin fibroblasts, and IL-4 and IL-13 mediate signal transduction through a common pathway | Q41011905 | ||
IL-10 induces gene expression in macrophages: partial overlap with IL-5 but not with IL-4 induced genes | Q42451430 | ||
Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism | Q43803694 | ||
Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. | Q44021327 | ||
IL-4 receptor signaling is required for mannose receptor expression by macrophages recruited to granulomata but not resident cells in mice infected with Schistosoma mansoni | Q44550687 | ||
Conditional gene targeting in macrophages and granulocytes using LysMcre mice. | Q44554898 | ||
Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent | Q44826352 | ||
A protective and agonistic function of IL-12p40 in mycobacterial infection. | Q46435226 | ||
Differences between IL-4R alpha-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses | Q47946081 | ||
Regulation of protective immunity against Leishmania major in mice | Q61313284 | ||
Superoxide production by stimulated neutrophils: temperature effect | Q68244788 | ||
Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines | Q71691379 | ||
Determination of arginase activity in macrophages: a micromethod | Q72182280 | ||
IL-4 plays a crucial role in regulating oxidative damage in the liver during schistosomiasis | Q73400795 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | macrophage | Q184204 |
schistosomiasis | Q221159 | ||
P304 | page(s) | 623-635 | |
P577 | publication date | 2004-05-01 | |
P1433 | published in | Immunity | Q6005457 |
P1476 | title | Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology | |
P478 | volume | 20 |
Q35201779 | 24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis |
Q36610541 | A Mutation in IL4RA Is Associated with the Degree of Pathology in Human TB Patients |
Q40550780 | A chronic rhinosinusitis-derived isolate of Pseudomonas aeruginosa induces acute and pervasive effects on the murine upper airway microbiome and host immune response |
Q28478122 | A family of helminth molecules that modulate innate cell responses via molecular mimicry of host antimicrobial peptides |
Q34500826 | A new strategy based on SmRho protein loaded chitosan nanoparticles as a candidate oral vaccine against schistosomiasis |
Q36438280 | A protective role for IL-13 receptor α 1 in bleomycin-induced pulmonary injury and repair |
Q30479825 | A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria |
Q35101462 | A role for peroxisome proliferator-activated receptors in the immunopathology of schistosomiasis? |
Q46888870 | A systemic granulomatous response to Schistosoma mansoni eggs alters responsiveness of bone-marrow-derived macrophages to Toll-like receptor agonists |
Q55040844 | A worm's eye view of the immune system: consequences for evolution of human autoimmune disease. |
Q38829051 | Aberrant immune response with consequent vascular and connective tissue remodeling - causal to scleroderma and associated syndromes such as Raynaud phenomenon and other fibrosing syndromes? |
Q35664969 | Advanced age impairs macrophage polarization |
Q33909537 | Adventitial fibroblasts induce a distinct proinflammatory/profibrotic macrophage phenotype in pulmonary hypertension |
Q35164318 | Allergic inflammation--innately homeostatic |
Q90218049 | Alternative Activation of Macrophages in Mice Peritoneal Cavities and Diaphragms by Newborn Larvae of Trichinella spiralis |
Q41644055 | Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. |
Q41631408 | Alternative Macrophage Activation Is Increased in Asthma |
Q39187810 | Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection |
Q35879015 | Alternative activation of macrophages and pulmonary fibrosis are modulated by scavenger receptor, macrophage receptor with collagenous structure |
Q40089523 | Alternative activation of ruminant macrophages by Fasciola hepatica |
Q37721788 | Alternatively Activated Macrophages Revisited: New Insights into the Regulation of Immunity, Inflammation and Metabolic Function following Parasite Infection |
Q36098786 | Alternatively Activated Mononuclear Phagocytes from the Skin Site of Infection and the Impact of IL-4Rα Signalling on CD4+T Cell Survival in Draining Lymph Nodes after Repeated Exposure to Schistosoma mansoni Cercariae |
Q37273324 | Alternatively activated macrophage-derived RELM-{alpha} is a negative regulator of type 2 inflammation in the lung. |
Q36911886 | Alternatively activated macrophages in helminth infections |
Q35527184 | Alternatively activated macrophages in intestinal helminth infection: effects on concurrent bacterial colitis |
Q26849454 | Alternatively activated macrophages in types 1 and 2 diabetes |
Q41807977 | Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. |
Q36247659 | Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitis |
Q35741426 | An IL-13 promoter polymorphism associated with liver fibrosis in patients with Schistosoma japonicum. |
Q36797270 | An efferocytosis-induced, IL-4-dependent macrophage-iNKT cell circuit suppresses sterile inflammation and is defective in murine CGD |
Q35742768 | An essential role for TH2-type responses in limiting acute tissue damage during experimental helminth infection |
Q40073176 | Anti-schistosome antibodies change NTPDase 1 activity from macrophages |
Q34064230 | Arginase I suppresses IL-12/IL-23p40-driven intestinal inflammation during acute schistosomiasis |
Q41414174 | Arginase activity in peripheral blood of patients with intestinal schistosomiasis, Wonji, Central Ethiopia |
Q37474041 | Arginase in parasitic infections: macrophage activation, immunosuppression, and intracellular signals |
Q40409458 | Arginase-1-expressing macrophages are dispensable for resistance to infection with the gastrointestinal helminth Trichuris muris. |
Q33429032 | Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis |
Q37395887 | Arginase: an emerging key player in the mammalian immune system |
Q42540536 | Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity |
Q33796509 | BALB/c mice deficient in CD4 T cell IL-4Rα expression control Leishmania mexicana Load although female but not male mice develop a healer phenotype |
Q90440088 | Batf2 differentially regulates tissue immunopathology in Type 1 and Type 2 diseases |
Q37027056 | Biosensor for Hepatocellular Injury Corresponds to Experimental Scoring of Hepatosplenic Schistosomiasis in Mice. |
Q33818866 | Blood fluke exploitation of non-cognate CD4+ T cell help to facilitate parasite development. |
Q27339697 | Blood flukes exploit Peyer's Patch lymphoid tissue to facilitate transmission from the mammalian host |
Q37699569 | Bosutinib Therapy Ameliorates Lung Inflammation and Fibrosis in Experimental Silicosis |
Q34161501 | CD11c depletion severely disrupts Th2 induction and development in vivo |
Q34059017 | CD14 influences host immune responses and alternative activation of macrophages during Schistosoma mansoni infection |
Q58780990 | CD18 Regulates Monocyte Hematopoiesis and Promotes Resistance to Experimental Schistosomiasis |
Q37730569 | CD28 and IL-4: two heavyweights controlling the balance between immunity and inflammation. |
Q37951519 | CD4+ T helper 2 cells--microbial triggers, differentiation requirements and effector functions |
Q27306067 | CD4+CD25+ regulatory cells contribute to the regulation of colonic Th2 granulomatous pathology caused by schistosome infection |
Q33325920 | Cationic amino acid transporter-2 regulates immunity by modulating arginase activity |
Q49989611 | Cell Type-Specific Immunomodulation Induced by Helminthes: Effect on Metainflammation, Insulin Resistance and Type-2 Diabetes. |
Q36939405 | Chronic helminth infections modulate allergen-specific immune responses: Protection against development of allergic disorders? |
Q35156780 | Circulating CD14brightCD16+ 'intermediate' monocytes exhibit enhanced parasite pattern recognition in human helminth infection |
Q34299395 | Circulating microbial products and acute phase proteins as markers of pathogenesis in lymphatic filarial disease |
Q99237958 | Clinical Use of Schistosoma mansoni Antigens as Novel Immunotherapies for Autoimmune Disorders |
Q37207458 | Cloning, expression, purification, crystallization and preliminary X-ray crystallographic analysis of interleukin-4-inducing principle from Schistosoma mansoni eggs (IPSE/alpha-1). |
Q36949978 | Coinfection with the intestinal nematode Heligmosomoides polygyrus markedly reduces hepatic egg-induced immunopathology and proinflammatory cytokines in mouse models of severe schistosomiasis. |
Q36043434 | Concurrent bacterial stimulation alters the function of helminth-activated dendritic cells, resulting in IL-17 induction. |
Q38046545 | Contribution of myeloid cell subsets to liver fibrosis in parasite infection |
Q43494254 | Control of Schistosoma mansoni egg-induced inflammation by IL-4-responsive CD4(+)CD25(-)CD103(+)Foxp3(-) cells is IL-10-dependent |
Q37706716 | Coordinating innate and adaptive immunity in Fasciola hepatica infection: implications for control. |
Q45140259 | Corilagin Counteracts IL-13Rα1 Signaling Pathway in Macrophages to Mitigate Schistosome Egg-Induced Hepatic Fibrosis |
Q88673786 | Cre Driver Mice Targeting Macrophages |
Q35908278 | Critical illness induces alternative activation of M2 macrophages in adipose tissue |
Q37209512 | Cytokine mediated tissue fibrosis |
Q27330347 | Dasatinib Reduces Lung Inflammation and Fibrosis in Acute Experimental Silicosis |
Q30564789 | Defense peptides secreted by helminth pathogens: antimicrobial and/or immunomodulator molecules? |
Q30445433 | Delayed goblet cell hyperplasia, acetylcholine receptor expression, and worm expulsion in SMC-specific IL-4Ralpha-deficient mice |
Q57055922 | Deletion of IL-4 Receptor alpha-responsive keratinocytes in BALB/c mice does not alter susceptibility to cutaneous leishmaniasis |
Q35034206 | Deletion of IL-4 receptor alpha on dendritic cells renders BALB/c mice hypersusceptible to Leishmania major infection. |
Q33284533 | Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection. |
Q37145507 | Dendritic cell IL-23 and IL-1 production in response to schistosome eggs induces Th17 cells in a mouse strain prone to severe immunopathology |
Q36296826 | Depletion of enteric bacteria diminishes leukocyte infiltration following doxorubicin-induced small intestinal damage in mice |
Q40403699 | Differential Macrophage Polarization from Pneumocystis in Immunocompetent and Immunosuppressed Hosts: Potential Adjunctive Therapy during Pneumonia |
Q33930501 | Differential expression of chemokine and matrix re-modelling genes is associated with contrasting schistosome-induced hepatopathology in murine models. |
Q33942518 | Differential polarization of alveolar macrophages and bone marrow-derived monocytes following chemically and pathogen-induced chronic lung inflammation. |
Q34364640 | Dynamic changes in macrophage activation and proliferation during the development and resolution of intestinal inflammation |
Q35905715 | E-cadherin expression in macrophages dampens their inflammatory responsiveness in vitro, but does not modulate M2-regulated pathologies in vivo |
Q39405568 | Effects of a recombinant schistosomal-derived anti-inflammatory molecular (rSj16) on the lipopolysaccharide (LPS)-induced activated RAW264.7. |
Q58575845 | Egg-Released IPSE/alpha-1 Dampens Inflammatory Cytokine Responses Basophil Interleukin (IL)-4 and IL-13 |
Q40653441 | Ellagic acid reduces murine schistosomiasis mansoni immunopathology via up-regulation of IL-10 and down-modulation of pro-inflammatory cytokines production. |
Q35016636 | Endogenous IL-13 plays a crucial role in liver granuloma maturation during Leishmania donovani infection, independent of IL-4Rα-responsive macrophages and neutrophils |
Q33621964 | Endogenously produced IL-4 nonredundantly stimulates CD8+ T cell proliferation |
Q38961697 | Enteric helminth-induced type I interferon signaling protects against pulmonary virus infection through interaction with the microbiota. |
Q91720874 | Eosinophils and Macrophages within the Th2-Induced Granuloma: Balancing Killing and Healing in a Tight Space |
Q34031152 | Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. |
Q36932394 | Eosinophils secrete IL-4 to facilitate liver regeneration |
Q37381695 | Epigenetic regulation of the alternatively activated macrophage phenotype |
Q33884582 | Epithelial interleukin-4 receptor expression promotes colon tumor growth |
Q33789378 | Erythropoietin signaling: a novel regulator of white adipose tissue inflammation during diet-induced obesity |
Q34443099 | Evidence of microbial translocation associated with perturbations in T cell and antigen-presenting cell homeostasis in hookworm infections |
Q37887778 | Evolution of IL4 and pathogen antagonism. |
Q33904042 | Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens. |
Q59391845 | Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease |
Q41941686 | Exacerbated egg-induced immunopathology in murine Schistosoma mansoni infection is primarily mediated by IL-17 and restrained by IFN-γ. |
Q34257934 | Exacerbation of diabetic renal alterations in mice lacking vasohibin-1. |
Q34050010 | Expression of IL-4 receptor alpha on smooth muscle cells is not necessary for development of experimental allergic asthma. |
Q55340933 | Extracellular Vesicles From the Helminth Fasciola hepatica Prevent DSS-Induced Acute Ulcerative Colitis in a T-Lymphocyte Independent Mode. |
Q34595664 | Fasciola hepatica fatty acid binding protein induces the alternative activation of human macrophages |
Q35825861 | Fibrosis is regulated by Th2 and Th17 responses and by dynamic interactions between fibroblasts and macrophages |
Q37265682 | Fish immunity and parasite infections: from innate immunity to immunoprophylactic prospects |
Q27306771 | Fluorescent imaging of antigen released by a skin-invading helminth reveals differential uptake and activation profiles by antigen presenting cells |
Q38263962 | Frienemies of infection: A chronic case of host nuclear receptors acting as cohorts or combatants of infection |
Q35091527 | From inflammation to wound healing: using a simple model to understand the functional versatility of murine macrophages |
Q35762090 | GGTase-I deficiency reduces tumor formation and improves survival in mice with K-RAS-induced lung cancer |
Q35072410 | Galectin-1 in injured rat spinal cord: implications for macrophage phagocytosis and neural repair |
Q33551405 | Gastrointestinal nematode infection exacerbates malaria-induced liver pathology |
Q35758674 | GdCl3 Attenuates Schistosomiasis japonicum Egg-Induced Granulomatosis Accompanied by Decreased Macrophage Infiltration in Murine Liver |
Q57463003 | Gene Expression Differences in Host Response to Schistosoma haematobium Infection. |
Q33870916 | Genetic control of severe egg-induced immunopathology and IL-17 production in murine schistosomiasis |
Q42643724 | Genome-wide profiling of transcribed enhancers during macrophage activation |
Q41075081 | Genotype-Associated Arginase 1 Expression in Rat Peritoneal Macrophages Induced by Toxoplasma gondii |
Q36088115 | Granulocytes in helminth infection -- who is calling the shots? |
Q35208931 | Group 2 innate lymphoid cell proportions are diminished in young helminth infected children and restored by curative anti-helminthic treatment |
Q37693527 | Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages. |
Q54986943 | Helminth Infections: Recognition and Modulation of the Immune Response by Innate Immune Cells. |
Q37451115 | Helminth infection can reduce insulitis and type 1 diabetes through CD25- and IL-10-independent mechanisms |
Q34467996 | Helminth infection in populations undergoing epidemiological transition: a friend or foe? |
Q26829956 | Helminth infections and host immune regulation |
Q24648324 | Helminth infections: the great neglected tropical diseases |
Q37588918 | Helminth-induced Ly6Chi monocyte-derived alternatively activated macrophages suppress experimental autoimmune encephalomyelitis. |
Q37713327 | Helminth-induced interleukin-4 abrogates invariant natural killer T cell activation-associated clearance of bacterial infection |
Q34844755 | Helminths and their implication in sepsis - a new branch of their immunomodulatory behaviour? |
Q34620969 | Helminths, allergic disorders and IgE-mediated immune responses: where do we stand? |
Q35624730 | Histone deacetylase 3 is an epigenomic brake in macrophage alternative activation. |
Q39847816 | Hookworm-induced persistent changes to the immunological environment of the lung. |
Q39181829 | Host lung immunity is severely compromised during tropical pulmonary eosinophilia: role of lung eosinophils and macrophages |
Q38229984 | Host protective roles of type 2 immunity: parasite killing and tissue repair, flip sides of the same coin. |
Q38615196 | Host regulation of liver fibroproliferative pathology during experimental schistosomiasis via interleukin-4 receptor alpha |
Q49426078 | House dust mite induced allergic airway disease is attenuated in CD11ccreIL-4Rα-/l°x mice. |
Q42514705 | Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. |
Q33382323 | IFN-gamma-dependent regulatory circuits in immune inflammation highlighted in diabetes |
Q35951830 | IFN-γ-driven IDO production from macrophages protects IL-4Rα-deficient mice against lethality during Schistosoma mansoni infection |
Q34064182 | IL-10 and TGF-beta redundantly protect against severe liver injury and mortality during acute schistosomiasis |
Q34145683 | IL-10R blockade during chronic schistosomiasis mansoni results in the loss of B cells from the liver and the development of severe pulmonary disease. |
Q38757038 | IL-13-Mediated Regulation of Learning and Memory. |
Q37647886 | IL-13Rα1 is a surface marker for M2 macrophages influencing their differentiation and function |
Q36267150 | IL-31-IL-31R interactions negatively regulate type 2 inflammation in the lung |
Q24309034 | IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation |
Q93047810 | IL-4 Mediated Resistance of BALB/c Mice to Visceral Leishmaniasis Is Independent of IL-4Rα Signaling via T Cells |
Q49792920 | IL-4 Receptor Alpha Signaling through Macrophages Differentially Regulates Liver Fibrosis Progression and Reversal. |
Q92931594 | IL-4 controls activated neutrophil FcγR2b expression and migration into inflamed joints |
Q37246528 | IL-4 directly signals tissue-resident macrophages to proliferate beyond homeostatic levels controlled by CSF-1 |
Q84852500 | IL-4(-/-) mice with lethal Mesocestoides corti infections--reduced Th2 cytokines and alternatively activated macrophages |
Q41997519 | IL-4-producing B cells regulate T helper cell dichotomy in type 1- and type 2-controlled diseases. |
Q36579161 | IL-4/IL-13 independent goblet cell hyperplasia in experimental helminth infections. |
Q37071862 | IL-4/IL-13-dependent alternative activation of macrophages but not microglial cells is associated with uncontrolled cerebral cryptococcosis |
Q34067170 | IL-4R alpha expression by bone marrow-derived cells is necessary and sufficient for host protection against acute schistosomiasis |
Q37278398 | IL-4Ralpha responsiveness of non-CD4 T cells contributes to resistance in schistosoma mansoni infection in pan-T cell-specific IL-4Ralpha-deficient mice. |
Q33587299 | IL-4Ralpha-independent expression of mannose receptor and Ym1 by macrophages depends on their IL-10 responsiveness |
Q54513153 | IL-4R{alpha}-responsive smooth muscle cells increase intestinal hypercontractility and contribute to resistance during acute Schistosomiasis. |
Q42654168 | IL-4Rα Signaling in Keratinocytes and Early IL-4 Production Are Dispensable for Generating a Curative T Helper 1 Response in Leishmania major-Infected C57BL/6 Mice. |
Q91345235 | IL-4Rα expression by airway epithelium and smooth muscle accounts for nearly all airway hyperresponsiveness in murine allergic airway disease |
Q27311168 | IL-4Rα-dependent alternative activation of macrophages is not decisive for Mycobacterium tuberculosis pathology and bacterial burden in mice |
Q64947965 | IL-4Rα-expressing CD11c+ cells contribute to driving optimal cellular responses during Schistosoma mansoni infection in mice. |
Q43592011 | IL-4Rα-responsive smooth muscle cells contribute to initiation of TH2 immunity and pulmonary pathology in Nippostrongylus brasiliensis infections. |
Q36638151 | IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality |
Q55280335 | IPSC‑MSC inhibition assessment in Raw 264.7 cells following oxygen and glucose deprivation reveals a distinct function for cardiopulmonary resuscitation. |
Q34979643 | Identification and distribution of developing innate lymphoid cells in the fetal mouse intestine |
Q38755567 | Immune polarization by hookworms: taking cues from T helper type 2, type 2 innate lymphoid cells and alternatively activated macrophages. |
Q38247208 | Immune responses to Schistosoma haematobium infection |
Q36385717 | Immunomodulatory glycan LNFPIII alleviates hepatosteatosis and insulin resistance through direct and indirect control of metabolic pathways |
Q36220509 | Immunopathology of schistosomiasis |
Q41727507 | Immunoproteasome dysfunction augments alternative polarization of alveolar macrophages |
Q41480089 | Immunoregulation by Taenia crassiceps and its antigens |
Q45354857 | Inactivated Orf virus (Parapoxvirus ovis) elicits antifibrotic activity in models of liver fibrosis. |
Q34166520 | Incomplete deletion of IL-4Rα by LysM(Cre) reveals distinct subsets of M2 macrophages controlling inflammation and fibrosis in chronic schistosomiasis. |
Q40143861 | Increased levels of Gab1 and Gab2 adaptor proteins skew interleukin-4 (IL-4) signaling toward M2 macrophage-driven pulmonary fibrosis in mice |
Q35091220 | Inducible deletion of CD28 prior to secondary nippostrongylus brasiliensis infection impairs worm expulsion and recall of protective memory CD4⁺ T cell responses |
Q36949600 | Induction and regulation of pathogenic Th17 cell responses in schistosomiasis |
Q38202992 | Induction of regulatory cells by helminth parasites: exploitation for the treatment of inflammatory diseases |
Q33740902 | Induction of type 2 responses by schistosome worms during prepatent infection |
Q59329436 | Infection-Induced Transcriptional Changes in Hepatic Macrophage Metabolism Correlate With an Athero-Protective Phenotype |
Q35649461 | Infectious disease, the innate immune response, and fibrosis |
Q39191329 | Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice |
Q28307203 | Innate and adaptive type 2 immune cell responses in genetically controlled resistance to intestinal helminth infection |
Q35073787 | Innate immune responses to lung-stage helminth infection induce alternatively activated alveolar macrophages |
Q33900037 | Innate scavenger receptor-A regulates adaptive T helper cell responses to pathogen infection |
Q33769549 | Interleukin 4 promotes the development of ex-Foxp3 Th2 cells during immunity to intestinal helminths |
Q34787194 | Interleukin-13 (IL-13)/IL-13 receptor alpha1 (IL-13Ralpha1) signaling regulates intestinal epithelial cystic fibrosis transmembrane conductance regulator channel-dependent Cl- secretion. |
Q54650095 | Interleukin-25 fails to activate STAT6 and induce alternatively activated macrophages. |
Q35665393 | Interleukin-4 (IL-4) and IL-13 suppress excessive neutrophil infiltration and hepatocyte damage during acute murine schistosomiasis japonica |
Q60949709 | Interleukin-4 Receptor Alpha Expressing B Cells Are Essential to Down-Modulate Host Granulomatous Inflammation During Schistosomasis |
Q47156219 | Interleukin-4 Receptor Alpha: From Innate to Adaptive Immunity in Murine Models of Cutaneous Leishmaniasis |
Q55333225 | Interleukin-4 activated macrophages mediate immunity to filarial helminth infection by sustaining CCR3-dependent eosinophilia. |
Q36711467 | Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. |
Q34491845 | Interleukin-5 (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity. |
Q35952040 | Interspecies comparison of human and murine scleroderma reveals IL-13 and CCL2 as disease subset-specific targets |
Q33590452 | Intestinal epithelial cell secretion of RELM-beta protects against gastrointestinal worm infection |
Q38054004 | Kidney injury molecule-1: more than just an injury marker of tubular epithelial cells? |
Q41214702 | Klf4 expression in conventional dendritic cells is required for T helper 2 cell responses. |
Q41764241 | Kupffer cells ameliorate hepatic insulin resistance induced by high-fat diet rich in monounsaturated fatty acids: the evidence for the involvement of alternatively activated macrophages |
Q40614757 | LIM-only protein FHL2 regulates experimental pulmonary Schistosoma mansoni egg granuloma formation |
Q40216211 | Local amplifiers of IL-4Rα-mediated macrophage activation promote repair in lung and liver |
Q35083309 | Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation |
Q39374107 | Long non-coding RNAs (lncRNAs) and their transcriptional control of inflammatory responses |
Q57799068 | Loss of Stat6 affects chromatin condensation in intestinal epithelial cells causing diverse outcome in murine models of inflammation-associated and sporadic colon carcinogenesis |
Q33587133 | Low transformation growth factor-β1 production and collagen synthesis correlate with the lack of hepatic periportal fibrosis development in undernourished mice infected with Schistosoma mansoni. |
Q33814920 | Lung tumor growth is stimulated in IFN-gamma-/- mice and inhibited in IL-4Ralpha-/- mice. |
Q42258458 | Lung-resident CD4⁺ T cells are sufficient for IL-4Rα-dependent recall immunity to Nippostrongylus brasiliensis infection. |
Q27328478 | Ly6C(high) monocytes become alternatively activated macrophages in schistosome granulomas with help from CD4+ cells |
Q34075772 | Ly6Chi monocyte recruitment is responsible for Th2 associated host-protective macrophage accumulation in liver inflammation due to schistosomiasis |
Q43117216 | MIF homologues from a filarial nematode parasite synergize with IL-4 to induce alternative activation of host macrophages |
Q90601875 | Macrophage Activation and Functions during Helminth Infection: Recent Advances from the Laboratory Mouse |
Q36935291 | Macrophage M1/M2 polarization dynamically adapts to changes in cytokine microenvironments in Cryptococcus neoformans infection |
Q36128289 | Macrophage activation governs schistosomiasis-induced inflammation and fibrosis |
Q36955562 | Macrophage diversity in renal injury and repair. |
Q40199450 | Macrophage fusion induced by IL-4 alternative activation is a multistage process involving multiple target molecules |
Q36692041 | Macrophage heterogeneity in respiratory diseases |
Q29547620 | Macrophage plasticity and polarization: in vivo veritas |
Q47386444 | Macrophage polarization and meta-inflammation |
Q27007951 | Macrophage proliferation, provenance, and plasticity in macroparasite infection |
Q40091029 | Macrophage-Restricted Shp2 Tyrosine Phosphatase Acts as a Rheostat for MMP12 through TGF-β Activation in the Prevention of Age-Related Emphysema in Mice. |
Q34875797 | Macrophage-derived human resistin is induced in multiple helminth infections and promotes inflammatory monocytes and increased parasite burden. |
Q29614354 | Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance |
Q34067326 | Macrophages and immunologic inflammation of the kidney |
Q91569404 | Macrophages assemble! But do they need IL-4R during schistosomiasis? |
Q26851960 | Macrophages in intestinal homeostasis and inflammation |
Q58600016 | Macrophages promote epithelial proliferation following infectious and non-infectious lung injury through a Trefoil factor 2-dependent mechanism |
Q34076279 | Macrophages: master regulators of inflammation and fibrosis |
Q37000620 | Mapping immune response profiles: the emerging scenario from helminth immunology. |
Q29620307 | Mechanisms of fibrosis: therapeutic translation for fibrotic disease |
Q35956683 | Memory T(H)2 cells induce alternatively activated macrophages to mediate protection against nematode parasites |
Q37604634 | MicroR-146 blocks the activation of M1 macrophage by targeting signal transducer and activator of transcription 1 in hepatic schistosomiasis |
Q92408379 | MicroRNA Regulated Macrophage Activation in Obesity |
Q43520272 | MicroRNA profiling reveals opposing expression patterns for miR-511 in alternatively and classically activated macrophages |
Q37546938 | Microbial Translocation Associated with an Acute-Phase Response and Elevations in MMP-1, HO-1, and Proinflammatory Cytokines in Strongyloides stercoralis Infection |
Q36136118 | Minor genomic differences between related B6 and B10 mice affect severity of schistosome infection by governing the mode of dendritic cell activation. |
Q37686798 | Monocyte subsets in schistosomiasis patients with periportal fibrosis |
Q35949214 | Mouse Model of Cat Allergic Rhinitis and Intranasal Liposome-Adjuvanted Refined Fel d 1 Vaccine |
Q34693180 | Multiple helminth infection of the skin causes lymphocyte hypo-responsiveness mediated by Th2 conditioning of dermal myeloid cells. |
Q37724688 | Murine schistosomiasis as a model for human schistosomiasis mansoni: similarities and discrepancies |
Q59280514 | Myeloid cell-specific expression of Ship1 regulates IL-12 production and immunity to helminth infection |
Q41106752 | Myeloid expression of the AP-1 transcription factor JUNB modulates outcomes of type 1 and type 2 parasitic infections. |
Q37808167 | Myeloid-derived suppressor cells in parasitic infections |
Q83293334 | Neither interleukin-4 receptor alpha expression on CD4+ T cells, or macrophages and neutrophils is required for protective immunity to Trichinella spiralis |
Q37361936 | New insights into the roles of dendritic cells in intestinal immunity and tolerance |
Q34533347 | Nippostrongylus-induced intestinal hypercontractility requires IL-4 receptor alpha-responsiveness by T cells in mice |
Q35607506 | Novel effector molecules in type 2 inflammation: lessons drawn from helminth infection and allergy |
Q35917062 | Nuclear receptor ERR alpha and coactivator PGC-1 beta are effectors of IFN-gamma-induced host defense |
Q34683631 | Obstacles and opportunities for understanding macrophage polarization |
Q30601730 | Omega-1 knockdown in Schistosoma mansoni eggs by lentivirus transduction reduces granuloma size in vivo |
Q37174214 | On the hunt for helminths: innate immune cells in the recognition and response to helminth parasites |
Q59806954 | Origin, Differentiation, and Function of Intestinal Macrophages |
Q24682128 | Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation |
Q59357241 | PSTPIP2 connects DNA methylation to macrophage polarization in CCL4-induced mouse model of hepatic fibrosis |
Q44857079 | PTEN functions to 'prioritize' chemotactic cues and prevent 'distraction' in migrating neutrophils |
Q43631328 | Paired immunoglobulin-like receptor-B inhibits pulmonary fibrosis by suppressing profibrogenic properties of alveolar macrophages |
Q37695081 | Parasitic helminths: new weapons against immunological disorders |
Q24669864 | Parasitic worms and inflammatory diseases |
Q93075393 | Pathogenesis of fibrostenosing Crohn's disease |
Q37695084 | Peroxisome proliferator-activated receptor (PPAR): balance for survival in parasitic infections |
Q39308787 | Pneumocystis infection alters the activation state of pulmonary macrophages |
Q28274980 | Polarization of host immune responses by helminth-expressed glycans |
Q41935070 | Porcine alveolar macrophage polarization is involved in inhibition of porcine reproductive and respiratory syndrome virus (PRRSV) replication |
Q41911191 | Possible role for Toll-like receptors in interaction of Fasciola hepatica excretory/secretory products with bovine macrophages |
Q35208353 | Preexisting helminth infection induces inhibition of innate pulmonary anti-tuberculosis defense by engaging the IL-4 receptor pathway |
Q36247356 | Priming of the immune response by schistosome eggs |
Q47674870 | Protection from EAE by IL-4Ralpha(-/-) macrophages depends upon T regulatory cell involvement |
Q44830476 | Protection of cattle against a natural infection of Fasciola hepatica by vaccination with recombinant cathepsin L1 (rFhCL1). |
Q35925405 | Protective Effect of Chronic Schistosomiasis in Baboons Coinfected with Schistosoma mansoni and Plasmodium knowlesi |
Q38096294 | Protective and pathological roles of mast cells and basophils |
Q36481763 | Protective immune mechanisms in helminth infection |
Q36023909 | Protein kinase C delta is essential for optimal macrophage-mediated phagosomal containment of Listeria monocytogenes. |
Q28073072 | Purinergic signaling in schistosomal infection |
Q41890902 | Quantification and localization of M2 macrophages in human kidneys with acute tubular injury. |
Q33796715 | Rapid host defense against Aspergillus fumigatus involves alveolar macrophages with a predominance of alternatively activated phenotype |
Q90236078 | Recombinant Sj16 protein with novel activity alleviates hepatic granulomatous inflammation and fibrosis induced by Schistosoma japonicum associated with M2 macrophages in a mouse model |
Q35637946 | Recombinant adeno-associated virus-mediated inhibition of microRNA-21 protects mice against the lethal schistosome infection by repressing both IL-13 and transforming growth factor beta 1 pathways |
Q38785193 | Recruited Monocytes and Type 2 Immunity Promote Lung Regeneration following Pneumonectomy |
Q92668520 | Recruitment of hepatic macrophages from monocytes is independent of IL-4Rα but is associated with ablation of resident macrophages in schistosomiasis |
Q35961926 | Redefining the transcriptional regulatory dynamics of classically and alternatively activated macrophages by deepCAGE transcriptomics. |
Q47414963 | Regnase-1 and Roquin Nonredundantly Regulate Th1 Differentiation Causing Cardiac Inflammation and Fibrosis. |
Q38411808 | Regulation of immunity by Taeniids: lessons from animal models and in vitro studies |
Q31141885 | Regulation of innate responses during pre-patent schistosome infection provides an immune environment permissive for parasite development |
Q30434189 | Regulation of learning and memory by meningeal immunity: a key role for IL-4 |
Q42846090 | Regulation of the development of the hepatic B cell compartment during Schistosoma mansoni infection |
Q40664477 | Regulatory parameters of the lung immune response during the early phase of experimental trichinellosis |
Q37103941 | Reverse genetics and the study of the immune response to schistosomes |
Q36373253 | Reversibility of Stricturing Crohn's Disease-Fact or Fiction? |
Q35207665 | Rhinovirus infection induces interleukin-13 production from CD11b-positive, M2-polarized exudative macrophages |
Q27010514 | Role of IL-4Rα during acute schistosomiasis in mice |
Q28067627 | Role of Macrophages in the Repair Process during the Tissue Migrating and Resident Helminth Infections |
Q34700777 | Role of arginase 1 from myeloid cells in th2-dominated lung inflammation. |
Q34346340 | SPI-1 encoded genes of Salmonella Typhimurium influence differential polarization of porcine alveolar macrophages in vitro |
Q59127674 | Schistosoma "Eggs-Iting" the Host: Granuloma Formation and Egg Excretion |
Q37373127 | Schistosoma mansoni arginase shares functional similarities with human orthologs but depends upon disulphide bridges for enzymatic activity. |
Q36974469 | Schistosoma mansoni egg antigen-mediated modulation of Toll-like receptor (TLR)-induced activation occurs independently of TLR2, TLR4, and MyD88 |
Q36506127 | Schistosoma mansoni hemozoin modulates alternative activation of macrophages via specific suppression of Retnla expression and secretion. |
Q54787200 | Selective induction of the Notch ligand Jagged-1 in macrophages by soluble egg antigen from Schistosoma mansoni involves ERK signalling. |
Q36635594 | Signal transducer and activator of transcription factor 6 signaling contributes to control host lung pathology but favors susceptibility against Toxocara canis infection. |
Q34166632 | Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin |
Q33633305 | Similarity and diversity in macrophage activation by nematodes, trematodes, and cestodes. |
Q36743554 | Suppression of TH2-type allergic reactions by helminth infection. |
Q35930499 | Surfactant Protein-D Is Essential for Immunity to Helminth Infection. |
Q90055083 | T Lymphocyte-Mediated Liver Immunopathology of Schistosomiasis |
Q35928348 | T helper1/t helper2 cells and resistance/susceptibility to leishmania infection: is this paradigm still relevant? |
Q42110315 | T-bet protects against exacerbation of schistosome egg-induced immunopathology by regulating Th17-mediated inflammation |
Q36606601 | T-helper 17 cells are associated with pathology in human schistosomiasis |
Q42825944 | TGF-β limits IL-33 production and promotes the resolution of colitis through regulation of macrophage function |
Q36204162 | TGF-β-responsive myeloid cells suppress type 2 immunity and emphysematous pathology after hookworm infection |
Q35607342 | TH1-dominant granulomatous pathology does not inhibit fibrosis or cause lethality during murine schistosomiasis |
Q81245724 | TLR9 activation is a key event for the maintenance of a mycobacterial antigen-elicited pulmonary granulomatous response |
Q36093909 | TPL-2 Regulates Macrophage Lipid Metabolism and M2 Differentiation to Control TH2-Mediated Immunopathology. |
Q55315292 | Targeting Macrophages in Cancer: From Bench to Bedside. |
Q37143365 | Th2 cell hyporesponsiveness during chronic murine schistosomiasis is cell intrinsic and linked to GRAIL expression |
Q35884210 | Th2 response polarization during infection with the helminth parasite Schistosoma mansoni |
Q38058759 | Th2 responses in schistosomiasis. |
Q35565153 | Th2-associated alternative Kupffer cell activation promotes liver fibrosis without inducing local inflammation |
Q61805993 | The C-type Lectin Receptor-Driven, Th17 Cell-Mediated Severe Pathology in Schistosomiasis: Not All Immune Responses to Helminth Parasites Are Th2 Dominated |
Q41915030 | The C-type lectin SIGNR1 binds Schistosoma mansoni antigens in vitro, but SIGNR1-deficient mice have normal responses during schistosome infection |
Q37346633 | The CCL7-CCL2-CCR2 axis regulates IL-4 production in lungs and fungal immunity |
Q58090901 | The Foxp3+ regulatory T-cell population requires IL-4Rα signaling to control inflammation during helminth infections |
Q43082287 | The IL-13/IL-4Rα axis is involved in tuberculosis-associated pathology |
Q34682153 | The IL-21 receptor augments Th2 effector function and alternative macrophage activation |
Q36659528 | The Metabolic Prospective and Redox Regulation of Macrophage Polarization |
Q35222060 | The Schistosoma mansoni hepatic egg granuloma provides a favorable microenvironment for sustained growth of Leishmania donovani |
Q34072227 | The absence of MyD88 has no effect on the induction of alternatively activated macrophage during Fasciola hepatica infection |
Q37016241 | The divergent roles of alternatively activated macrophages in helminthic infections. |
Q50692950 | The immunity of splenic and peritoneal F4/80(+) resident macrophages in mouse mixed allogeneic chimeras. |
Q40108993 | The immunomodulatory glycan LNFPIII initiates alternative activation of murine macrophages in vivo |
Q26851643 | The impact of the myeloid response to radiation therapy |
Q36576209 | The linkage of innate and adaptive immune response during granulomatous development |
Q36843026 | The pathogenic Th17 cell response to major schistosome egg antigen is sequentially dependent on IL-23 and IL-1β |
Q53083007 | The protective effect of the recombinant 53-kDa protein of Trichinella spiralis on experimental colitis in mice. |
Q33358673 | The role of B-cells and IgM antibodies in parasitemia, anemia, and VSG switching in Trypanosoma brucei-infected mice |
Q92332665 | The role of microRNAs in the pathogenesis, grading and treatment of hepatic fibrosis in schistosomiasis |
Q36764281 | The schistosoma granuloma: friend or foe? |
Q34485066 | The schistosome glutathione S-transferase P28GST, a unique helminth protein, prevents intestinal inflammation in experimental colitis through a Th2-type response with mucosal eosinophils |
Q36850831 | The schistosome in the mammalian host: understanding the mechanisms of adaptation |
Q60910445 | The state of art of neutrophil extracellular traps in protozoan and helminthic infections |
Q35833768 | Tim-3 induces Th2-biased immunity and alternative macrophage activation during Schistosoma japonicum infection |
Q38003021 | Tissue microenvironments define and get reinforced by macrophage phenotypes in homeostasis or during inflammation, repair and fibrosis. |
Q39116477 | Tissue tolerance: a distinct concept to control acute GVHD severity. |
Q38068399 | Tissues use resident dendritic cells and macrophages to maintain homeostasis and to regain homeostasis upon tissue injury: the immunoregulatory role of changing tissue environments. |
Q42949359 | Toll-like receptor 9 activation is a key mechanism for the maintenance of chronic lung inflammation |
Q38772394 | Toxoplasma gondii GRA15II effector-induced M1 cells ameliorate liver fibrosis in mice infected with Schistosomiasis japonica |
Q42836798 | Toxoplasma gondii peroxiredoxin promotes altered macrophage function, caspase-1-dependent IL-1β secretion enhances parasite replication |
Q54224374 | Transcriptional landscape of Mycobacterium tuberculosis infection in macrophages. |
Q37949245 | Transcriptional regulation of macrophage polarization: enabling diversity with identity |
Q60912266 | Transplantation of bone marrow mesenchymal stromal cells attenuates liver fibrosis in mice by regulating macrophage subtypes |
Q38943102 | Triggering receptor expressed on myeloid cells (TREM)-1 participates in Schistosoma mansoni inflammatory responses. |
Q35052425 | Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells |
Q36946566 | Tuning sensitivity to IL-4 and IL-13: differential expression of IL-4Ralpha, IL-13Ralpha1, and gammac regulates relative cytokine sensitivity |
Q38424752 | Type 2 cytokines: mechanisms and therapeutic strategies |
Q56834653 | Type 2 immune response associated with silicosis is not instrumental in the development of the disease |
Q37238286 | Type 2 innate lymphoid cells constitutively express arginase-I in the naive and inflamed lung |
Q37102222 | Umbilical cord-derived mesenchymal stem cells alleviate liver fibrosis in rats |
Q37217252 | Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha1 chain |
Q28082281 | Unraveling the Hygiene Hypothesis of helminthes and autoimmunity: origins, pathophysiology, and clinical applications |
Q34395286 | Upregulation of retinal dehydrogenase 2 in alternatively activated macrophages during retinoid-dependent type-2 immunity to helminth infection in mice |
Q40462535 | Vanin-1 controls granuloma formation and macrophage polarization in Coxiella burnetii infection. |
Q40240298 | Vitamin A mediates conversion of monocyte-derived macrophages into tissue-resident macrophages during alternative activation |
Q92523630 | hUCMSC-extracellular vesicles downregulated hepatic stellate cell activation and reduced liver injury in S. japonicum-infected mice |
Q34924612 | mTOR inhibition rescues osteopenia in mice with systemic sclerosis |
Q90189626 | ncRNAs in Type-2 Immunity |
Q36916423 | p16INK4a deficiency promotes IL-4-induced polarization and inhibits proinflammatory signaling in macrophages. |
Search more.